Paul Hastings partner Eric Dittmann/courtesy photo
Paul Hastings partner Eric Dittmann says he hopes Mitsubishi Tanabe's voluntary agreement with Zydus Pharmaceuticals to extend the Hatch-Waxman automatic stay will serve as a model for others.
April 29, 2020 at 01:49 PM
1 minute read
Kumbaya moments aren’t easy to come by in most pharmaceutical litigation.
But with a May bench trial postponed due to COVID-19 concerns, drug companies litigating the validity of patents on a diabetes treatment have jointly agreed to extend the Hatch-Waxman Act’s automatic stay against launching a generic product.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
